|
PSCI-23-020 |
A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naive High Grade Non-Muscle Invasive Bladder Cancer (BRIDGE) EA8212 |
|
PSCI-23-064 |
A Pilot Study of Patient Priorities Care in Older Adults with Non-Muscle-Invasive Bladder Cancer |
|
PSCI-23-067 |
An Intermediate Expanded Use Trial of DFMO(eflornithine HCl) |
|
PSCI-23-079 |
A Phase II Study of Naxitamab Added to Induction Therapy for Subjects with Newly DiagnosedHigh-Risk Neuroblastoma |
|
PSCI-23-092 |
A Phase II/III trial of Durvalumab and Chemotherapy for Patients with High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy EA8192 |
|
PSCI-23-099 |
NRG-BR009: A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score (OFSET) |
|
PSCI-23-121 |
Phase III Randomized Trial of Stereotactic ablative radiotherapy (SAbR) for Oligometastatic Advanced Renal Carcinoma (SOAR) |
|
PSHCI-08-065 |
Biologic Studies of Experimental Anti-Cancer Therapeutics in Human Leukemia Cells |
|
PSHCI-08-079 |
Children's Lives Include Moments of Bravery (CLIMB) |
|
PSHCI-09-052 |
The Collection of Blood, Tissue and Phenotypic Data in Patients Diagnosed with Skin Cancers and Subsequent Metastases for Inclusion in a Repository and Use in Outcome Studies |
